- Home
- OIS vs OCGN Comparison
OIS vs OCGN Comparison
Compare OIS & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OIS
- OCGN
- Stock Information
- Founded
- OIS 1995
- OCGN 2013
- Country
- OIS United States
- OCGN United States
- Employees
- OIS N/A
- OCGN N/A
- Industry
- OIS Metal Fabrications
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OIS Industrials
- OCGN Health Care
- Exchange
- OIS Nasdaq
- OCGN Nasdaq
- Market Cap
- OIS 352.6M
- OCGN 321.7M
- IPO Year
- OIS 2001
- OCGN N/A
- Fundamental
- Price
- OIS $6.57
- OCGN $1.52
- Analyst Decision
- OIS Hold
- OCGN Strong Buy
- Analyst Count
- OIS 1
- OCGN 2
- Target Price
- OIS $5.50
- OCGN $7.00
- AVG Volume (30 Days)
- OIS 515.4K
- OCGN 5.9M
- Earning Date
- OIS 10-31-2025
- OCGN 11-05-2025
- Dividend Yield
- OIS N/A
- OCGN N/A
- EPS Growth
- OIS N/A
- OCGN N/A
- EPS
- OIS 0.11
- OCGN N/A
- Revenue
- OIS $664,287,000.00
- OCGN $4,754,000.00
- Revenue This Year
- OIS N/A
- OCGN N/A
- Revenue Next Year
- OIS $5.16
- OCGN N/A
- P/E Ratio
- OIS $60.63
- OCGN N/A
- Revenue Growth
- OIS N/A
- OCGN N/A
- 52 Week Low
- OIS $3.08
- OCGN $0.52
- 52 Week High
- OIS $6.80
- OCGN $1.90
- Technical
- Relative Strength Index (RSI)
- OIS 62.24
- OCGN 48.14
- Support Level
- OIS $5.77
- OCGN $1.47
- Resistance Level
- OIS $6.80
- OCGN $1.65
- Average True Range (ATR)
- OIS 0.25
- OCGN 0.11
- MACD
- OIS 0.05
- OCGN -0.04
- Stochastic Oscillator
- OIS 80.59
- OCGN 12.50
About OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").